HLA-G and gastric cancer: The results (Table 2) showed that the HLA-G expression status in PTTs was significantly associated with the survival of patients with GC, with those having HLA-G-negative PTTs demonstrating longer survival than those with HLA-G-positive PTTs (56.7 months vs. 42.0 months, p=0.023; Figure 2A).